Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Belenkov IuN"'
Autor:
Shakar'iants Ga, N V Khabarova, M V Kozhevnikova, Kaplunova VIu, E. V. Privalova, Belenkov IuN
Publikováno v:
Kardiologiia. :4-7
Prognosis of patients with hypertrophic cardiomyopathy (HCMP) to a great extent is determined by clinical variant of the disease. As the system of matrix metalloproteinases (MMPs) plays an important role in development and progression of the processe
Publikováno v:
Kardiologiia. 54(4)
AIM 1) to create Perimitral Atrial Flutter (PMAFL) model and estimate theoretical probability of elimination of perimital reetntry using left atrial geometry two-dimensional mathematical modeling and ablative formatting; 2) to compare clinical result
Publikováno v:
Kardiologiia. 54(3)
Keeping in mind an important role of renin-angiotensin aldosterone system (RAS) in developing of cardiac remodeling and fibrosis, genetic polymorphisms coding its components could have influence with clinical variants of the course. Biomarkers could
Publikováno v:
ResearcherID
Europe PubMed Central
Europe PubMed Central
Aim of the study was to assess effect of myocardial revascularization on levels of factors of angiogenesis in early and remote period after intervention. Main group comprised 228 patients with ischemic heart disease (n=228, 194 men, 34 women, mean ag
Publikováno v:
Europe PubMed Central
To study immune mechanisms of inflammation in dilated cardiomyopathy (DCM).The study of main markers of immune activation was conducted in 44 patients with DCM with stage I - IIB and NYHA functional class (FC) I - IV chronic heart failure (CHF). Amon
Autor:
Sa, Gabrusenko, Vv, Malakhov, Igor Sergienko, Me, Bugriĭ, Ma, Saidova, Vv, Kukharchuk, Belenkov IuN
Publikováno v:
ResearcherID
Europe PubMed Central
Europe PubMed Central
To assess effect of programmed external counterpulsation (ECP) on clinico-functional status, quality of life of patients with chronic heart failure (CHF) of ischemic origin, stable functional class (FC) II-IV angina refractory to drug therapy.Patient
Autor:
Lapina IuV, Narusov OIu, Mareev VIu, Mg, Bolotina, Mv, Shestakova, Vp, Masenko, Gn, Litonova, Ne, Arzamastseva, Na, Baklanova, Belenkov IuN
Publikováno v:
Europe PubMed Central
Aim of the investigation was to study safety of therapy with metformin and its effect on clinical, hemodynamic, functional and neurohumoral status in patients with chronic heart failure and type 2 diabetes mellitus DM). Eighty one patients with light
Autor:
Igor Sergienko, Ae, Semenova, Vp, Masenko, Mv, Ezhov, Sa, Gabrusenko, Vv, Kukharchuk, Belenkov IuN
Publikováno v:
Europe PubMed Central
The aim of our study was to assess the influence of rosuvastatin on coronary angiogenesis. 30 male patients with chronic coronary heart disease and total cholesterol level5.2 mmol/l were treated with rosuvastatin 10 mg daily during 3 months. The seru
Autor:
Aa, Skvortsov, Mareev VIu, Sn, Nasonova, Av, Sychev, Gn, Arbolishvili, Na, Baklanova, Vp, Masenko, Belenkov IuN
Publikováno v:
Europe PubMed Central
To assess different variants of neurohormonal (NH) modulation with angiotensin converting enzyme (ACE-I) quinapril (Q), angiotensin-receptor blocker (ARB) valsartan (V) and their combination in addition to beta-adrenergic blocker bisoprolol (B) on fu
Autor:
Aa, Skvortsov, Sn, Nasonova, Av, Sychev, Gn, Arbolishvili, Na, Baklanova, Mareev VIu, Belenkov IuN
Publikováno v:
Europe PubMed Central
To compare effects of various regimens of long-term monotherapy with quinapril (an ACE inhibitor) and valsartan (a type 1 angiotensin II receptors blocker) and combined therapy with these drugs on the activity of heurohormonal systems and 24-h heart